Safely correct hyponatremia with continuous renal replacement therapy: A flexible, all‐purpose method based on the mixing paradigm
Physiological Reports · 2023
DOI: 10.14814/phy2.15496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2023. Verfasst von Sheldon Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Nephrology, MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Hyponatremia, Continuous Renal Replacement Therapy, Acute Kidney Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Treating chronic hyponatremia by continuous renal replacement therapy (CRRT) is challenging because the gradient between a replacement fluid's [sodium] and a patient's serum sodium can be steep, risking too rapid of a correction rate with possible consequences. Besides CRRT, other gains and losses of sodium‐ and potassium‐containing solutions, like intravenous fluid and urine output, affect the correction of serum sodium over time, known as osmotherapy. The way these fluids interact and contribute to the sodium/potassium/water balance can be parsed as a mixing problem. As Na/K/H 2 O are added, mixed in the body, and drained via CRRT, the net balance of solutes must be related to the change in serum sodium, expressible as a differential equation. Its solution has many variables, one of which is the sodium correction rate, but all variables can be evaluated by a root‐finding technique. The mixing paradigm is proved to replicate the established equations of osmotherapy, as in the special case of a steady volume. The flexibility to solve for any variable broadens our treatment options. If the pre‐filter replacement fluid cannot be diluted, then we can compensate by calculating the CRRT blood flow rate needed. Or we can deduce the infusion rate of dextrose 5% water, post‐filter, to appropriately slow the rise in serum sodium. In conclusion, the mixing model is a generalizable and practical tool to analyze patient scenarios of greater complexity than before, to help doctors customize a CRRT prescription to safely and effectively reach the serum sodium target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Nephrology, MD Anderson Cancer Center, Houston, Texas, USA.
- Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan, USA.
- Internal Medicine, SUNY Downstate, New York, New York, USA.
ORCID-Profile: Sheldon Chen
Zitieren
APA
Chen, S., Yee, J., & Chiaramonte, R. (2023). Safely correct hyponatremia with continuous renal replacement therapy: A flexible, all‐purpose method based on the mixing paradigm. Physiological Reports. https://doi.org/10.14814/phy2.15496
Vancouver
Chen S, Yee J, Chiaramonte R. Safely correct hyponatremia with continuous renal replacement therapy: A flexible, all‐purpose method based on the mixing paradigm. Physiological Reports. 2023. doi:10.14814/phy2.15496
BibTeX
@article{Chen2023,
author = {Chen, Sheldon and Yee, Jerry and Chiaramonte, Robert},
title = {Safely correct hyponatremia with continuous renal replacement therapy: A flexible, all‐purpose method based on the mixing paradigm},
journal = {Physiological Reports},
year = {2023},
doi = {10.14814/phy2.15496}
}
EUVIMED